Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Long-Term Investments: 2024-2025

Historic Long-Term Investments for Praxis Precision Medicines (PRAX) over the last 2 years, with Sep 2025 value amounting to $122.0 million.

  • Praxis Precision Medicines' Long-Term Investments rose 125.35% to $122.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.0 million, marking a year-over-year increase of 125.35%. This contributed to the annual value of $77.0 million for FY2024, which is N/A change from last year.
  • Praxis Precision Medicines' Long-Term Investments amounted to $122.0 million in Q3 2025, which was down 16.07% from $145.4 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Long-Term Investments registered a high of $145.4 million during Q2 2025, and its lowest value of $35.9 million during Q1 2024.
  • For the 2-year period, Praxis Precision Medicines' Long-Term Investments averaged around $94.3 million, with its median value being $82.0 million (2024).
  • Data for Praxis Precision Medicines' Long-Term Investments shows a peak YoY soared of 301.51% (in 2025) over the last 5 years.
  • Over the past 2 years, Praxis Precision Medicines' Long-Term Investments (Quarterly) stood at $77.0 million in 2024, then spiked by 125.35% to $122.0 million in 2025.
  • Its last three reported values are $122.0 million in Q3 2025, $145.4 million for Q2 2025, and $144.0 million during Q1 2025.